After a selection process, Torrecárdenas University Hospital will participate in the implementation of the FOCUS program. The FOCUS program has been underway since 2010 and it aims to provide early diagnosis of infections such as HIV and Hepatitis C in hospitals and health centers. This is possible thanks to the agreement between the Andalusian Health […]
Read More
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]
Read More
European Commission authorises second safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed […]
Read More
EU and AU sign partnership to scale up preparedness for health emergencies
The European Centre for Disease Prevention and Control (ECDC) and the Africa Centres for Disease Control and Prevention (Africa CDC) is today launching a new four-year partnership initiative in order to enhance mutual engagement and contribute to durably strengthening Africa CDC capacities in preparedness and response to health threats. Entitled ‘EU for health security in […]
Read More
European Commission authorises first safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency […]
Read More
The Council and the European Parliament agree provisionally on the EU4Health programme for 2021-2027
The German presidency of the Council and the European Parliament reached a provisional deal on the EU4Health programme for 2021-2027. With a budget of EUR 5.1 billion, the new reinforced programme provides a strong basis for Union action in the health field based on lessons learned during the COVID-19 pandemic. It comes at a time […]
Read More
Waging war against SARS-CoV-2 with Europe’s most powerful supercomputers
Searching for new COVID-19 treatments, an EU-funded project conducted a supercomputing experiment to study the interaction of over 70 billion antiviral molecules with SARS-CoV-2 proteins. A huge molecular computation experiment was recently conducted to identify new treatments against the SARS-CoV-2 virus. Run by the EU-funded EXSCALATE4CoV project, the experiment is believed to be the most […]
Read More
The EU will begin vaccination on December 27
The EU will begin vaccination on December 27. This is what the president of the European Commission Ursula von der Leyen has assured on her Twitter account: It’s Europe’s moment. On 27, 28 and 29 December vaccination will start across the EU. We protect our citizens together. We are #StrongerTogether#EUvaccinationdays pic.twitter.com/6VxDumysBL — Ursula von der […]
Read More
Andalusia designated as European Region of Sport for the year 2021
ACES Europe considers in its decision that the Andalusian community is a good example of sport for everyone as an instrument of health, integration, education and respect. The entity ACES Europe has designated Andalusia as European Region of Sport for the year 2021, after evaluating that the Andalusian community “is a good example of sport […]
Read More